Evaluation of Effect of Epidural Anaesthesia on Pulmonary Functions in Patients Undergoing Upper Abdominal Surgery Under General Anaesthesia: A Comparative Study on 82 Patients by Radhika, M
EVALUATION OF EFFECT OF EPIDURAL ANAESTHESIA 
ON PULMONARY FUNCTIONS IN PATIENTS 
UNDERGOING UPPER ABDOMINAL SURGERY UNDER 
GENERAL ANAESTHESIA 
A COMPARATIVE STUDY ON 82 PATIENTS 
 
DISSERTATION SUBMITTED FOR THE DEGREE OF 
DOCTOR OF MEDICINE 
BRANCH X (ANAESTHESIOLOGY) 
APRIL -2012 
 
 
THE TAMILNADU Dr. M.G.R MEDICAL UNIVERSITY 
CHENNAI 
TAMILNADU 
BONAFIDE CERTIFICATE 
 
This is to certify that this dissertation entitled “EVALUATION OF 
EFFECT OF EPIDURAL ANAESTHESIA ON PULMONARY 
FUNCTIONS IN PATIENTS UNDERGOING UPPER ABDOMINAL 
SURGERY UNDER GENERAL ANAESTHESIA” is a bonafide record 
work done by Dr.M.Radhika under my direct supervision and guidance, 
submitted to the Tamil Nadu Dr. M.G.R. Medical University in partial 
fulfilment of University regulation for MD, Branch X – Anaesthesiology. 
 
 
     PROF. Dr.T.THIRUNAVUKKARASU, M.D, D.A, 
Director, i/c.  
Institute Of Anaesthesiology, 
Govt. Madurai Medical College & Hospital 
Madurai. 
 
 
 
 
DECLARATION 
I Dr. M. RADHIKA solemnly declare that this dissertation titled 
“EVALUATION OF EFFECT OF EPIDURAL ANAESTHESIA ON 
PULMONARY FUNCTIONS IN PATIENTS UNDERGOING 
UPPER ABDOMINAL SURGERY UNDER GENERAL 
ANAESTHESIA” has been done by me. I also declare that this bonafide 
work or a part of this work was not submitted by me or any other for any 
award, degree or diploma to any other University or board either in India 
or abroad. 
This is submitted to The Tamilnadu Dr. M. G. R. Medical 
University, Chennai in partial fulfillment of the rules and regulation for 
the award of Doctor of Medicine degree Branch –X (Anaesthesiology) to 
be held in April 2012. 
 
Place:  Madurai     Dr. M. RADHIKA 
Date: 
 
 
 
 
 
                                    ACKNOWLEDGEMENT 
I am deeply indebted to Dr.T.THIRUNAVUKKARASU,MD.,DA.,  
Professor & Director, i/c of the Institute of  Anaesthesiology, Madurai 
medical college, Madurai  for the able guidance, inspiration and 
encouragement he rendered at every stage of this study. 
I express my heartfelt gratitude to Dr.S.C.GANESH PRABU 
MD.,DA., Dr.R.SHANMUGAM,MD., Dr.A.PARAMASIVAN MD., 
DA.,  Professors, Institute of Anaesthesiology , for their able guidance in 
doing this project.  
          I express my profound thanks to Assistant Professor                   
Dr.S.SIVAPRASATH, MD., for his valuable suggestions and technical 
guidance in doing this study.        
         My profound thanks to Dr.EDWIN JOE, M.D., Dean, Madurai 
Medical College, Madurai for permitting to utilize the clinical materials 
of this hospital in the completion of my dissertation.  
           I am also thankful to my other assistant professors and my post 
graduate colleagues of Institute of Anaesthesiology and Department of 
Surgery, Madurai Medical College, Madurai for their kind co-operation in 
doing this study. Last, but not the least, I am grateful to the patients for 
submitting themselves for this study. 
CONTENTS 
Sl.
No. TOPICS 
Page 
No. 
1 INTRODUCTION   1 
2 AIM OF THE STUDY   6 
3 PULMONARY FUNCTION TEST   7 
4 SPIROMETER  16 
5 GENERAL ANAESTHESIA AND 
RESPIRATORY OUTCOME 
 20 
6 EPIDURAL ANALGESIA AND 
RESPIRATORY OUTCOME 
 31 
7 REVIEW OF LITERATURE   37 
8 MATERIALS AND METHODS   46 
9 ANALYSIS OF DATA  49 
10 OBSERVATIONS AND RESULTS  50 
11 DISCUSSION   58 
12 SUMMARY  62 
13 CONCLUSION  63 
14 BIBLIOGRAPHY  
15 PROFORMA  
16 MASTER CHART  
 
 
INTRODUCTION 
It is a well known fact that surgery and anaesthesia perturb the 
normal physiology of a patient. All the systems in the human body are 
affected and the pulmonary system is not an exception.  Many factors 
responsible for postoperative pulmonary dysfunction include anaesthetic, 
surgical and patient factors. 
Postoperative pulmonary dysfunction is an entity with multifactorial 
causes. The patient anaesthesia surgery triad act in an interdependent way 
in the pathogenesis of this dysfunction. 
       Anaesthetic factors can be directly  related  to the  disruption  of  
the  normal  activity  of  the  respiratory  muscles,  disruption  that  begins  
with  the  induction  of  anaesthesia  and  that  may  continue  into the  
postoperative  period.  At high doses, anaesthetics attenuate the activities 
of all respiratory muscles.  However,  at  moderate  depths  of  
anaesthesia,  anaesthetics  may  produce  respiratory depression  by  
altering  the  distribution  and  timing  of  neural  drive  to  the  respiratory  
muscles,  rather  than  by  producing  a global  depression  of   activity.  
Thus,  perioperative  respiratory  muscle  dysfunction  in many  
cases is  more  a  matter  of  a  lack  of  coordination  than  a  lack of  
overall activity.  As  with  other  complex  systems,  this  lack of  
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coordination  reduces  efficiency,   producing  hypoventilation.  In  
addition,  alteration of  the  chest  wall dynamics and dimensions alters 
the  underlying  lung,  decreasing  the  functional  residual  capacity and  
producing  atelectasis  in  dependent   lung  regions.  These and other 
effects produce the ventilation-perfusion inequalities characteristic of 
anaesthesia.            
     Other indirect factors that may contribute to postoperative pulmonary 
complications   include  
1. Reflex  stimulation  during  airway  instrumentation  and   release of  
inflammatory  mediators  by  drug  administration,  increasing airway  
resistance  and  limiting  expiratory  gas  flow  from  the  lung;  if  severe  
this  can  produce  hyperinflation  with  risk  of barotraumas  and  gas  
exchange  abnormalities. 
2. Impairment  of  normal  mucociliary  transport  by  anaesthetic  gases  and  
endotracheal  intubation  which  may  delay  clearance  of  pathogens  and  
promote  retention  of  secretions.                                                      
3. Impairment  of  lung  inflammatory  cell’s  function  by  prolonged  
anaesthesia and surgery, which could increase susceptibility  to  
postoperative  infections. 
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4. Impaired upper airway reflexes postoperatively, with may increase the risk 
of aspiration, and 
5. Incomplete reversal of neuromuscular blockade. 
These  effects  of  anaesthesia  can  persist  into  the postoperative   
period,  and through different  mechanisms, the effects  of  surgical  
trauma also come  into  play.  These  are  most pronounced  following  
thoracic  and  abdominal  surgery,  and  arise from  at  least  three  
mechanisms. 
First,  functional  disruption  of  respiratory  muscles  by incisions,  
even  after  surgical  repair,  may  impair  their effectiveness.  
Second, postoperative   pain   may   cause voluntary limitation of   
respiratory motion. Finally,  stimulation  of  the  viscera,  markedly  
decreases phrenic  motor  neuron  output  and  changes  the  activation  of  
other respiratory  muscles,  in  general  acting  to  minimize  diaphragmatic 
descent. 
Apart from the above anaesthetic and surgical reasons, patient 
factors including age, pre existing lung diseases, smoking, effort tolerance 
and obesity play major roles in determining the postoperative pulmonary 
dysfunction. 
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Postoperative  pulmonary  dysfunction  may  delay  recovery  and  
if  severe  can  be  life threatening. Hypoxia may impair wound healing 
and cognitive function especially in the elderly. Atelectasis predisposes 
patients to chest infections and chest infection predisposes to respiratory 
failure. 
During recovery from general anaesthesia, there is a gradual 
increase in neural and muscular activity. The resting pulmonary indices 
like tidal  volume recover in parallel with the reduction in plasma levels of 
drugs. But the forced indices of pulmonary function like FVC,PEFR,MBC  
which help in maintaining airway, clearing secretions, prevention of 
atelectasis and hypoxia recover in an unpredictable fashion that is 
dependent on patient, anaesthesia and surgery factors. 
It takes variable period of time for patients to regain their pre 
operative levels of pulmonary function. Before the recovery, they succumb 
to hypoxia, infection, poor wound healing and retained secretions. It is the 
duty of the anaesthesia care provider to reduce the impact of factors that 
cause the pulmonary dysfunction. 
Hence, it is clear that, when postoperative patients are relatively 
pain free, their pulmonary function is improved. They can readily expand 
their chest, breathe deeply, cough well and cooperate with physical 
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therapy. They are therefore less likely to develop atelectasis, hypoxia and 
pulmonary infection and more likely to recover quickly and uneventfully. 
Pain can be alleviated via intravenous opioids, NSAIDS or 
neuraxial blockade. Since the former has their own disadvantages like 
respiratory depression, gastritis and  PONV, the  beneficial aspects of 
neuraxial blockade has made its role in improving pulmonary function in 
the postoperative period overcoming those disadvantages. Of neuraxial 
analgesic techniques, epidural offers more versatile advantages of less 
hemodynamic effect, extendable duration, depth and area of analgesia. 
They also provide better suppression of surgical stress, positive 
effect on postoperative nitrogen balance, more stable cardiovascular 
haemodynamics, reduced blood loss, better peripheral vascular circulation 
and better postoperative pain relief.  
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AIM OF THE STUDY 
 
 This study was undertaken with the aim of evaluating the effect of 
epidural anaesthesia on pulmonary functions in patients undergoing upper 
abdominal surgeries under general anaesthesia. The dynamic parameters 
of lung function evaluated in the study are, 
1. FEV1 [Forced expiratory volume at 1st second] 
2. FVC [Forced vital capacity] 
3. PEFR [Peak expiratory flow rate] 
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PULMONARY FUNCTION TEST 
           Pulmonary function testing has come into widespread use since the 
1970s. This has been facilitated by several developments. From 
cumbersome spirometers, miniaturization and advances in computer 
technology, microprocessor devices have made portable and automated 
spirometers with fewer moving parts. Testing equipment, patient 
maneuvers, and testing techniques have become widely standardized 
throughout the world through the efforts of professional societies. Widely 
accepted normative parameters have been established. 
          Pulmonary function testing is a valuable tool for evaluating the 
respiratory system, representing an important adjunct to the patient history, 
various lung imaging studies, and invasive testing such as bronchoscopy 
and open-lung biopsy. Insight into underlying pathophysiology can often 
be gained by comparing the measured values for pulmonary function tests 
obtained on a patient at any particular point with normative values derived 
from population studies. The percentage of predicted normal is used to 
grade the severity of the abnormality. It is necessary for stratifying 
preoperative risk, and for diagnosing common diseases such as asthma and 
chronic obstructive pulmonary disease.  
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          Pulmonary function tests is a generic term used to indicate a battery 
of studies or maneuvers that may be performed using standardized 
equipment to measure lung function. Pumonary function tests can include 
simple screening spirometry, formal lung volume measurement, diffusing 
capacity for carbon monoxide, and arterial blood gases. These studies may 
collectively be referred to as a complete pulmonary survey. Before a 
spirogram can be meaningfully interpreted, it is necessary to understand 
the graphic data (the volume-time curve and the flow-volume loop) to 
ascertain whether the study meets certain well-defined acceptability and 
reproducibility standards. Tests that fail to meet these standards can 
provide useful information about minimum levels of lung function, but, in 
general, they should be interpreted cautiously. The interpretation strategy 
usually involves establishing a pattern of abnormality (obstructive, 
restrictive, or mixed), grading the severity of the abnormality, and 
assessing trends over time.  
PHYSIOLOGY 
         Basic concepts of normal pulmonary physiology that are involved in 
pulmonary function testing include mechanics (airflows and lung 
volumes), the ventilation-perfusion interrelationship, diffusion and gas 
exchange, and respiratory muscle or bellows strength. Ventilation is the 
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process of generating the forces necessary to move the appropriate 
volumes of air from the atmosphere to the alveoli to meet the metabolic 
needs of the body under a variety of conditions. Simply, the contraction of 
the diaphragm and other inspiratory muscles expands the thorax, 
generating negative pressure in the pleural space. One component of 
pleural pressure, known as transpulmonary pressure causes a flow of air 
into the airways and lungs (inspiration). When the transpulmonary and 
alveolar pressures equilibrate, airflow stops, the inspiratory muscles relax, 
and the lungs and chest wall elastic recoil raise pleural pressure, forcing air 
out of the lungs (expiration). 
         With a forced exhalation, the early portion of the spirometry 
maneuver is characterized by high flows, mostly from large airways, and 
the latter portion is characterized by low flows with a larger contribution 
from the smaller airways. Forced inspiration is generally not flow limited 
and is a function of overall muscular effort. In contrast, a variety of factors 
affect expiratory flow, including the overall driving pressure, airway 
diameter, overall distensibility of the lungs and chest wall, dynamic airway 
collapse (from a flow-limiting segment), and muscular effort. 
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PULMONARY FUNCTION TEST INDICES 
1. BEDSIDE TESTS 
2. STATIC TESTS 
Lung voumes and capacities 
3. DYNAMIC TESTS 
   Forced spirometry 
   Maximum breathing capacity 
   Flow volume loops 
   Assessment of respiratory muscle strength 
4. COMPLIANCE TESTS 
   Static compliance 
   Dynamic compliance 
   Chest wall compliance 
 
  In this study forced spirometry was used to compare the pulmonary 
function in two groups.  The following three forced indices were used: 
1. FEV1 
2.  FVC 
3. PEFR 
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FORCED EXPIRATORY VOLUME IN 1 SECOND 
They correlate with airway diameter and expiratory strength. The 
FEV1 is the most widely used parameter to measure the mechanical 
properties of the lungs. In normal persons, the FEV1 accounts for the 
greatest part of the exhaled volume from a spirometric maneuver and 
reflect mechanical properties of the large and the medium-sized airways. 
In a normal flow-volume loop, the FEV1 occurs at about 75% to 85% of 
the FVC. This parameter is reduced in obstructive and restrictive 
disorders.  
FORCED VITAL CAPACITY 
 
         FVC is a measure of lung volume and expiratory strength together. It 
is usually reduced in diseases that cause the lungs to be smaller. Such 
processes are generally termed restrictive and can include disorders of the 
lung parenchyma, such as pulmonary fibrosis, or of the bellows, including 
kyphoscoliosis, neuromuscular disease, and pleural effusion. However, a 
reduction in FVC is not always due to reduced total volumes and can occur 
in the setting of large lungs hyperinflated due to severe airflow obstruction 
and air trapping, as in emphysema. Reduced FVC can occur despite a 
normal or increased total lung volume. Therefore, FVC is not a reliable 
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indicator of total lung capacity or restriction, especially in the setting of 
airflow obstruction.  
The overall accuracy of the FVC for restriction is about 60%. 
FEV1/FVC Ratio, also called Tiffeneau index is used in the diagnosis of 
obstructive and restricted lung disease. It represent the proportion of 
forced vital capacity exhaled in first second. Normal value is 
approximately 80%. 
PEAK EXPIRATORY FLOW RATE 
 
Peak expiratory flow rate (PEFR) is the maximum flow rate 
generated during a forceful exhalation, starting from full lung inflation. 
Peak flow rate primarily reflects large airway flow and depends on the 
voluntary effort and muscular strength of the patient. Normal value is     
450 – 700L/min. 
Maximal airflow occurs during the effort-dependent portion of the 
expiratory maneuver, so low values may be caused by a less than maximal 
effort rather than by airway. 
PEF is appreciably larger if the maneuver is performed without 
pause immediately after the inspiration than if it is performed after a 
pause. If the maneuver is performed sufficiently forcefully in most 
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subjects PEF is determined by flow limitation in central, possibly also in 
more peripheral airways. 
Report the largest value of 3 correctly performed maneuvers, but the 
difference between the largest two should be less than 40 L/min; if the 
difference is larger, then have up to 2 extra efforts performed. If even then 
the two largest values differ by > 40 L/min, then report the largest one 
with a note to the effect that reproducible measurements could not be 
obtained. 
Daily variability in PEF is larger in asthmatics than in healthy 
subjects Predicted values of PEF are of little use in detecting lung disease, 
as variability between healthy subjects is large, so that a value within the 
normal range certainly does not rule out the presence of airway 
obstruction. 
In severe obstructive lung disease rapid and extensive dynamic 
airway compression during the forced maneuver contribute appreciably to 
initial maximum expiratory flow from the lungs; the severity of airway 
obstruction then tends to be underestimated from PEF. 
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PULMONARY FUNCTION TESTING MEASUREMENT 
Accurate spirometric pulmonary function testing has three components: 
1. A frequently calibrated spirometer that accurately records exhaled volume 
in relation to time during the forced expiration. 
2. A subject who inspires maximally and exhales as forcefully, smoothly, and 
completely as he can 
3. A technician who can calibrate the spirometer , coach the subject to 
perform maximal efforts and detect poor subject effort or expirations that 
are not continuous, maximal and completely recorded.  
PERFORMANCE OF THE TEST 
1. Explain the test 
2. Prepare the subject 
3. Enquire  about smoking, recent illness, medication use, etc. 
4. Measure weight and height without shoes 
5. Wash hands 
6. Instruct and demonstrate the test to the subject 
7. In this study, test was performed in the supine posture 
8. Have subject assume the correct posture 
9. Attach nose clip, place mouthpiece in mouth and close lips around the  
mouthpiece. 
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10. Inhale completely and rapidly with a pause of ,1 s at TLC 
11. Exhale maximally until no more air can be expelled. 
12. Repeat instructions as necessary, coaching vigorously 
13. Repeat for a minimum of three manoeuvres; no more than eight are 
usually required. 
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SPIROMETER 
 
The spirometer used in this study for testing pulmonary function was 
MICRO MEDICAL SUPER SPIRO 
         The Micro Medical SuperSpiro is a powerful and sophisticated 
desktop spirometer. This comprehensive suite of analysis and management 
software is packaged in a sleek, compact desktop unit with a built-in 
colour monitor and thermal printer powered by a rechargeable internal 
battery pack. Extra features include USB support and touch-screen 
facilities and a modern graphical user-interface. 
         The SuperSpiro includes a patient database which can store up to 
3000 patients. The spirometer uses the Micro Medical Digital Volume 
Transducer, an extremely stable form of volume transducer, which 
measures expired air directly at B.T.P.S (Body Temperature and Pressure 
with Saturated water vapour)24 thus avoiding the inaccuracies of 
temperature  corrections. This transducer is insensitive to the effects of 
condensation and temperature and avoids the need for individual 
calibration prior to performing a test. 
The SuperSpiro has many advanced features including a  colour 
LCD display giving real time Flow/Volume or Volume/Time curves, user 
MICRO MEDICAL SUPER SPIRO 
 
 
 
1 Super Spiro 
2  Micro Medical digital volume transducer 
3 Transducer housing 
4 Universal AC adapter 
5 Stylus x 3 
6 USB cables 
7 RS-232 cable 
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customisation of instrument functions, predicted values, and the ability to 
carry out pre and post bronchodilator, and bronchial challenge testing. 
The spirometry measurements, Flow/Volume loop, and 
Volume/Time curve may be printed at the time of testing or at any time 
subsequently from memory. One unique feature is the ability to expand the 
capabilities of the instrument by simply downloading new software 
modules supplied with other transducers.  
It is recommended that only the required tests be activated to reduce 
the selections required during operation. The spirometry test may be 
performed with force or relaxed expiration and inspiration, with or without 
prior tidal breathing. 
For spirometry tests - the age range should be from 7 to 110 years, and 
height from 110cm to 250cm. 
Recording of forced indices 
The spirometry screen is displayed showing the predicted Flow/ 
Volume curve as a dashed line, or a shaded area, depending on the setting. 
The predicted curve will only be displayed if the patient details have been 
entered. The arrows in the top right hand corner of the screen indicate that 
the left and right cursor keys are active. In this case they are used to 
change the display between the full or expiratory only flow/volume loop, 
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the full or expiratory only volume/time curve, or the child incentive 
display. A spirometry test may be performed with or without tidal 
breathing through the transducer. 
Instruct the patient to breathe in until their lungs are completely full, 
then seal their lips around the mouthpiece and blow out as hard and as fast 
as possible until they cannot push any more air out. Then to breathe in 
fully, immediately after the expiratory manoeuvre, thus completing the 
flow volume loop. 
The Flow/Volume loop is displayed as the patient performs the 
manoeuvre. At the end of the test, values for FEV1, FVC and PEF are 
displayed, together with the Flow/Volume loop, and a manoeuvre quality 
check to allow a decision to be made to accept or reject this blow. 
Quality Checks 
There are five quality checks24 performed on each spirometry 
manoeuvre to determine its acceptability. They are as follows: 
If the patient performs an acceptable manoeuvre ‘Good blow’ is 
displayed at the top of the screen. 
If the back extrapolated volume (BEV) was greater than 150ml then 
‘Slow start’ will appear. This indicates that the patient did not blast out the 
air quickly and evenly during the forced expiration. 
 START BREATHING 
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If the time to peak flow (PEFT) was greater than 120msec then 
‘poor effort’ will appear indicating a sluggish effort during the forced 
expiration. 
  If the forced expiratory time (FET) was less than 6 seconds 
and the change in exhaled volume during the last half second was more 
than 100mL Abrupt end’ will appear. The patient had stopped exhaling 
prematurely. 
If the expiratory flow exhibited a secondary peak then ‘Cough 
detected’ will be displayed. 
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GENERAL ANAESTHESIA AND RESPIRATORY OUTCOME 
Anesthesia causes an impairment in pulmonary function, whether the 
patient is breathing spontaneously or is ventilated mechanically after 
muscle paralysis. Impaired oxygenation of blood occurs in most patients 
who are anesthetized. Lung function remains impaired postoperatively, 
and clinically significant pulmonary complications can be seen in 1% to 
2% after minor surgery in up to 20% after upper abdominal and thoracic 
surgery. 
In 1964, Nunn showed that during routine anaesthesia and 
spontaneous ventilation, gas exchange was altered by shunt and uneven 
ventilation perfusion ratios.  
In the 1980s, atelectasis was shown by computed tomography  in 
anaesthetized patients—neonates as well as adult.20 Lung densities were 
seen in anaesthetized children and were called ‘confluent high absorptive 
areas’ but such areas were not found in the scans performed under 
sedation.  
Thus clearly general anaesthesia poses the following various 
pulmonary complications: 
1. Atelectasis 
2.  Hypoxemia 
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3. Ventilation perfusion mismatch 
4. Respiratory drive reduction 
5. Reduced compliance and increased resistance. 
1.ATELECTASIS 
 These occur in the most dependent parts of the lungs and are found 
in almost 90% of all patients who are anaesthetized. They develop with 
both intravenous and inhalational anaesthesia and whether the patient is 
breathing spontaneously or is paralysed and ventilated mechanically.  
Good correlations have been found between gas exchange 
impairment and the amount of atelectasis. Most atelectasis occurs near the 
diaphragm in the supine patient and less towards the apex. Atelectasis may 
contain 15–20% of the lung tissue close to the diaphragm and about 10% 
of the total lung tissue. Atelectasis can persist for two days after major 
surgery. 
Pulmonary atelectasis may be caused by a variety of factors, which 
have been classified into three basic mechanisms. Compression atelectasis 
occurs when the transmural pressure distending the alveolus is reduced. 
Absorption atelectasis occurs when less gas enters the alveolus than is 
removed by uptake by the blood. Loss‐of‐surfactant atelectasis occurs 
when the surface tension of an alveolus increases because of reduced 
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surfactant action. Any of these factors may contribute to atelectasis during 
anaesthesia and the postoperative period. 
Compression Atelectasis 
The rapid formation of atelectasis on induction of anaesthesia, and 
the fast reappearance after discontinuation of PEEP suggested that the 
atelectasis was caused by compression of lung tissue rather than by 
resorption of gas behind occluded airways. Loss of inspiratory muscle tone 
is an important factor in atelectasis formation. It may thus be that the 
greater abdominal pressure is more easily transmitted into the thoracic 
cavity when the diaphragm has a reduced tone or is paralysed, as during 
anaesthesia.20  
The classic study by Froese and Bryan showed that diaphragm 
motion in spontaneously breathing normal volunteers is changed when the 
volunteers are paralysed with neuromuscular blocking agents. Hence 
Froese and Bryan concluded that in the supine position during spontaneous 
ventilation, the dependent part of the diaphragm had the greatest 
displacement. However, after neuromuscular block and positive pressure 
ventilation, exactly the opposite was seen: the non‐dependent part had the 
greatest displacement. 
23 
 
 Also, Krayer et al using CT scans, found altered diaphragmatic 
motion during general anaesthesia and mechanical ventilation. In addition, 
Warner et al found alterations in the end‐expiratory position of chest wall 
structures during general anaesthesia  and Reber et al showed that general 
anaesthesia induced a cephalad displacement of the most dorsal part of the 
diaphragm. Thus, compression atelectasis occurs during general 
anaesthesia and is caused by chest geometry and diaphragm position and 
motion. 
Absorption atelectasis 
Absorption atelectasis can occur by two mechanisms. The first 
mechanism is complete airway occlusion, which creates a pocket of 
trapped gas in the distal lung unit.20 The pressure in the pocket initially is 
close to atmospheric pressure. Mixed venous blood continues to perfuse 
the pocket, and since the sum of the gas partial pressures in the mixed 
venous blood is subatmospheric, gas uptake from the pocket by the blood 
continues and the pocket collapses.  
The second mechanism is when the inspired V/Q ratio is less than a critical 
value. If the inspired V/Q ratio of a lung unit is reduced, a point is reached 
where the rate at which inspired gas entering the alveolus is exactly 
balanced by gas uptake from the alveolus into the blood.20 This point is 
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known as the critical V/Q ratio. If the inspired V/Q ratio is less than this, 
the lung unit will collapse. This is likely when FiO2 is high and the gas 
uptake is large.  
Loss‐of‐surfactant atelectasis 
  Atelectasis, can impede surfactant function so that  a region is 
prone to collapse again after having been reopened.20 A vital capacity 
manoeuvre may promote surfactant production or release, and distribution 
of surfactant over the alveolar surface may cause a longer lasting 
protection against new collapse. Indeed, it has been shown that large gasps 
increase the proportion of active forms of alveolar surfactant. 
2.HYPOXEMIA 
Several factors contribute to hypoxemia in general anaesthesia.  
1. After induction of general anesthesia, there is a loss of the inspiratory tone 
and an appearance of end-expiratory tone in the abdominal expiratory 
muscles at the end of exhalation. The end-expiratory tone in the abdominal 
expiratory muscles increases intra-abdominal pressure, forces the 
diaphragm cephalad, and decreases FRC. Thus, after the induction of 
general anesthesia, there is loss of a force tending to maintain lung volume 
and gain of a force tending to decrease lung volume.  
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2. In the upright position, the FRC and the position of the diaphragm are 
determined by the balance between the lung elastic recoil pulling the 
diaphragm cephalad and the weight of the abdominal contents pulling it 
caudad. There is no transdiaphragmatic pressure gradient. But in supine 
position, the diaphragm separates two compartments of markedly different 
hydrostatic gradients. On the thoracic side, pressure increases by 
approximately 0.25 cm H2O/cm of lung height, and on the abdominal side 
by 1.0 cm H2O/cm of abdominal height. Hence in supine position, 
progressively higher transdiaphragmatic pressures must be generated 
toward dependent parts of the diaphragm to keep the abdominal contents 
out of the thorax. In the unparalyzed patient, this tension is developed 
either by passive stretch and shape changes of the diaphragm (causing an 
increased contractile force) or by neurally mediated active tension. With 
acute muscle paralysis, neither of these two mechanisms can operate, and a 
shift of the diaphragm to a more cephalad position occurs . The latter 
position must express the true balance of forces on the diaphragm, 
unmodified by any passive or active muscle activity. The cephalad shift in 
the FRC position of the diaphragm owing to expiratory muscle tone during 
general anesthesia is equal to the shift observed during paralysis. The 
equal shift suggests that the pressure on the diaphragm caused by an 
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increase in expiratory muscle tone during general anesthesia is equal to the 
pressure on the diaphragm caused by the weight of the abdominal contents 
during paralysis. 
3. The overall reduction in all components of lung volume during anesthesia 
results in a reduced caliber of airway, which increases airway resistance 
and any tendency toward airway collapse. The decreases in FRC caused by 
the supine position and the induction of anesthesia lead to increased 
resistance of the airway seen in the healthy anesthetized patient.  
4. In the supine position, the abdominal contents force the diaphragm 
cephalad and reduce the FRC.  The Trendelenburg position allows the 
abdominal contents to push the diaphragm further cephalad, so that the 
diaphragm not only must ventilate the lungs, but it also must lift the 
abdominal contents out of the thorax. The result is a predisposition to 
decreased FRC and atelectasis.  Increased pulmonary blood volume and 
gravitational force on the mediastinal structures are additional factors that 
may decrease pulmonary compliance and FRC. In the steep Trendelenburg 
position, most of the lung may be below the left atrium and therefore in a 
zone 3 or 4 condition. As such, the lung may be susceptible to the 
development of pulmonary interstitial edema.  
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5. Acute arterial hypoxemia from a transient right-to-left shunt through a 
patent foramen ovale has been described, particularly during emergence 
from anesthesia.   However, unless there is a real-time technique of 
imaging the cardiac chambers (color-flow Doppler mapping), it is difficult 
to document an acute and transient right-to-left intracardiac shunt as a 
cause of arterial hypoxemia. 
3.VENTILATION-PERFUSION(V/Q)MISMATCH 
           Ideally, ventilation should match perfusion perfectly (V/Q = 1) at 
the alveolus, but there is always some mismatch. Both CO2 elimination 
and oxygenation of blood are impaired in most patients during anesthesia. 
The impeded CO2 elimination can be attributed to increased dead space 
ventilation. Single-breath washout recordings have demonstrated that 
“anatomic” dead space is unchanged, indicating that the “alveolar” or 
physiological dead space must have increased during anesthesia..  
General anesthesia tends to increase mismatch in 2 possible ways:  
1) High V/Q (> 1 to ∞) occurs when perfusion is low compared with 
ventilation because of increased dead space. Dead space in an anesthetized 
patient includes the following: 
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•   Mechanical dead space, or portions of the breathing circuit in which  
there is no separation of inspired and expired gas streams (excessively 
long endotracheal tubes or extensions of the Y-connector) 
•  Anatomic dead space, or airways are not involved in gas exchange. 
•   Physiologic dead space are those that are being ventilated but not 
perfused due to low cardiac output, pulmonary arterial hypotension, 
cardiopulmonary arrest, or pulmonary thromboembolism; increased 
physiologic dead space can also be classified as a type of perfusional 
hypoxia 
2) Low V/Q (< 1 to 0) occurs when ventilation is low compared with 
perfusion, and effectively causes a right-to-left shunt. Shunt occurs 
whenever blood passes from the right to left side of the circulation without 
exposure to oxygen.  Normal shunt fraction is about 5% because venous 
blood from the myocardial and bronchial circulations empties into the left 
ventricle.  
Recumbency, general anesthesia, and positive intrathoracic pressure 
predispose to the development of atelectasis, which effectively causes 
shunting of blood from the right to the left side of the circulation without 
exposure to oxygen (these alveoli are perfused but not well ventilated).  
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Oxygen uptake is greatly compromised by shunt, resulting in low PaO2, 
even with supplemental oxygen. Carbon dioxide elimination is not 
compromised until the shunt is very severe (> 50%) because of its high 
diffusibility. 
4. REDUCTION OF RESPIRATORY DRIVE 
Anesthesia reduces the response to hypoxia. Attenuation of the 
hypoxic response may be attributed to an effect on the carotid body 
chemoreceptors. The effect of an anesthesia on respiratory muscles is 
nonuniform. Rib cage excursions diminish with deepening anesthesia. The 
normal ventilatory response to CO2 is produced by the intercostal muscles. 
Thus, the reduced ventilatory response to CO2 during anesthesia is due to 
impeded function of the intercostal muscles.1 
5. REDUCED COMPLIANCE AND INCREASED RESISTANCE 
      Total thoracic compliance = 100ml/cm H2O:  
Lung compliance = 200ml/cm H2o 
      Thoracic compliance = 200ml/cm H2o 
Static compliance of the total respiratory system (lungs and chest 
wall) is reduced on average from 95 to 60 ml/cm H2O during anesthesia. 
Several studies on lung compliance have been carried out during 
anesthesia, and the vast majority of studies indicate a decrease in 
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comparison to the awake state (e.g., static lung compliance fell from a 
mean of 187 ml/cm H2O awake to 149 ml/cm H2O during anesthesia.1 
There are also studies on resistance of the total respiratory system 
and the lungs during anesthesia, most of them showing a considerable 
increase during both spontaneous breathing and mechanical ventilation. 
The increased lung resistance merely reflects reduced FRC during 
anesthesia.  
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EPIDURAL ANALGESIA AND RESPIRATORY OUTCOME 
Postoperative  pulmonary  dysfunction  occurs  as  a  result  of  
surgery  and anesthesia-related  physiologic  perturbations  and  remains  a  
major  cause  of postoperative  morbidity.  Thus,  techniques  that  reduce  
postoperative  pulmonary  dysfunction  may  result  in  improved  clinical  
outcome. 
          It  has  recently  been  suggested  that  major  complications  
associated  with  epidural  analgesia  might  be  more  common  than  once  
thought, hence   it  is  of the  utmost  importance  to  have  a  clear  view  
of  the  real  benefits  associated with  its  use. An  updated  reappraisal  of  
the  benefits  associated  with  epidural analgesia  could  help the  clinician  
to  decide  when  the  benefits  of  an  epidural catheter  insertion  outweigh  
its  inherent  risks  in  a  specific  patient.  The  aim  of  this  review  is  to  
sum  up  the  benefits  of  adding  epidural  analgesia  for patients  operated  
on  under  general  anesthesia  emphasizing  the  improvement  of  
postoperative  pulmonary  function. 
         Epidural  local  anesthetics, with  or  without  opioids,  provide 
 better postoperative  pain  relief  than  systemic  opioids.  Epidural  local  
anesthetics reduce  central  sympathetic  stimulation, with   subsequent 
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favorable  effects  on coagulation  and  homeostasis  and  on  
gastrointestinal,  metabolic,  and  immune function. 
          Epidural  analgesia  significantly  increased  forced  vital  capacity  at  
24 hours, forced  expiratory  volume  in  1 second  at  24 hours, and  peak  
expiratory  flow rate  at  24 hours .  Epidural  analgesia  significantly  
increased  arterial  oxygen pressure  at  24  and  72 hours. 14 
Upper  abdominal  and  thoracic  incisions  significantly  reduce  
post operative  pulmonary  function.  Pulmonary  dysfunction  after  upper  
abdominal surgery  occurs  because  of  pain,  abnormal  diaphragmatic  
function,  and increased  abdominal  and  lower  intercostal  muscle  tone  
during exhalation.  Pulmonary dysfunction  begins  with  incision  and  
remains undiminished  for  7-14 days  postoperatively.  The  most  
important  alteration  of respiratory  function  is  decreased  functional  
residual  capacity,  which  begins about  16 h  postoperatively,  reaches  a  
nadir  at  24-48 h,  and  usually  resolves within  1  week.   Decreased  
functional  residual  capacity  may  result  in atelectasis  and  ventilation-
perfusion  abnormalities  leading  to  hypoxemia, pneumonia,  and  
postoperative  pulmonary  complications.  Patients  especially  at risk  for  
reduction  of  functional  residual  capacity  and  resultant  pulmonary 
complications  include  those  with  preexisting  pulmonary  
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disease,  upper abdominal  and  thoracic  incisions,  advanced  age,  
obesity,  and  those  in  severe pain. 
         Choice of anesthetic technique affects  the  degree  of  postoperative 
pulmonary  dysfunction.  Use of  general anesthesia  may  briefly  
exacerbate surgery-induced  pulmonary  dysfunction.  Mechanical  
ventilation,  paralysis, inhaled anesthetics,  and  opioids  all  contribute  to  
reduce  pulmonary  function.  In  contrast  to  the  exacerbation  of  
postoperative  pulmonary  dysfunction  seen with  general  anesthesia,  
TEA  has  minimal  effect  on  pulmonary  function  and may  offset  
detrimental  changes  in  pulmonary  function  induced  by  general 
anesthesia 
          Many   studies  suggest  that  postoperative  use  of  epidural  
analgesia  has the  potential  to  reduce  pulmonary  morbidity  by  
providing  better  analgesia, improved  diaphragmatic  function,  and  
reduced  frequency  and  severity  of postoperative  hypoxemia.  Epidural   
analgesia  using local anaesthetic or opioid,  and  especially  both  provides  
better  analgesia  than  systemic  opioid, including  delivery  by  
intravenous  PCA.  Because  relief  of  pain  improves pulmonary  function  
after  abdominal  or  thoracic  surgery,  it  is  not  surprising that  use  of  
epidural  analgesia  is  associated  with  improved  pulmonary  function  
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when  compared  with  intramuscular  and  intravenous  opioid.5  But  not 
all  studies  demonstrating  superior  analgesia  in  the  epidural  group  
also demonstrate  improvements  in  pulmonary  function  suggests  that  
factors  other than  pain  are  also  important  etiologic  factors  for  
postoperative  pulmonary impairment. 
          Diaphragmatic  function  is  impaired  after  abdominal  or  thoracic  
surgery and  may  also  contribute  to  pulmonary  dysfunction.  
Diaphragmatic  dysfunction  appears  to   result  from  reflex  inhibition  of  
phrenic  nerve activity  and  is  not  significantly  altered  by  relief  of  
pain.  Thus,  analgesia provided  with  parenteral  or  epidural  
administration  of  opioids  alone  does  not produce  appreciable  
improvement  in  diaphragmatic  function.  On  the  other hand,  thoracic  
epidural  blockade  with  local  anesthetic  may  improve postoperative  
diaphragmatic  function.14 This  improvement  in  function  probably 
results  from  neural  blockade  of  the  inhibitory  reflex22  and  perhaps  
through changes in chest  wall  compliance.  Thus, epidural  administration  
of   local anesthetics  for  postoperative  analgesia  can  result  in  
improved  pulmonary function  in  part  through  relief  of  pain  but  also  
by  improving  postoperative diaphragm  function.14 
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         Pulmonary dysfunction may also produce morbidity through 
hypoxemia.  Episodic  hypoxemia  is  common  in  the  postoperative  
period, particularly  during  sleep.23  Postoperative  hypoxemia  serves  as  
a  marker  for patients  with  postoperative  pulmonary  morbidity  and  is  
associated  with myocardial  ischemia.  Analgesia  with  either  parenteral  
or  epidural  opioid  is associated  with  equally  high  incidences  of  
episodic  postoperative hypoxemia.  However, use  of  epidural  analgesia  
with  local  anesthetics  is associated  with  a  reduced  incidence  and  
severity  of  hypoxemia  in  the  early postoperative  period   perhaps  
because  of  improved  pulmonary  function  or reduced  sedation.  
         Postoperative  pulmonary  dysfunction  can  be  attenuated  by  the  
intraoperative  use  of  epidural  local  anaesthetics.  More  important, 
continuation  of  epidural  analgesia  with  local  anaesthetic  into  the  
postoperative period  may  maintain  improvements  in  postoperative  
pulmonary  function.14 These  effects  may  be  attributable   to  the  
benefits  in  addition  to  analgesia provided  by  epidural  administration  
of  local  anaesthetics,  such  as  limitation  of the  degree  of  
postoperative  diaphragmatic  dysfunction,  improvement  of abdominal  or  
chest  wall  compliance,  and  limitation  of  episodes  of postoperative  
hypoxemia.  
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          In  summary, the  improvements  resulting  from  epidural  analgesia  
can  be attributed  to: 
• Effective  pain  relief  allowing  the  patient  to  take  deep  breaths, cough  
and  cooperate  with  physiotherapy; 
• Blocking  of  reflexes  inhibiting  diaphragmatic  function, demonstrable  
after  abdominal  and  thoracic  surgery,  is  likely  to have  a  beneficial  
effect on  pulmonary  mechanics; 
• Avoidance  of   high-dose  systemic  opioids  should  reduce respiratory  
depression;  and 
• Reduction of the stress response to surgery  reduces  the  level  of 
postoperative  immunosuppression,  which  may  contribute  to  a 
reduction  in  pulmonary  infection.14 
 
 
 
 
 
 
37 
 
REVIEW OF LITERATURE 
1. H. Hendolin et al, Acta Anaesthesiologica Scandinavica, Volume 
31, Issue 7, pages 645–651, October 1987;  
A prospective randomized trial was conducted to assess the effect of 
thoracic epidural analgesia (TEA) on postoperative respiratory function 
and pulmonary complications in patients undergoing cholecystectomy. 
One hundred patients were allocated to TEA (n = 30), TEA + general 
anaesthesia (TEA + GA) (n = 30), or general anaesthesia (GA) (n = 40) 
groups. Respiratory function was analysed by measuring forced vital 
capacity (FVC), forced expiratory volume in 1 s (FEV1), functional 
residual capacity (FRC), total lung capacity (TLC), peak expiratory flow 
(PEF) in the supine and sitting postures, and arterial blood gases.They 
concluded that TEA significantly prevented the postoperative 
deterioration of respiratory function as compared with patients who 
underwent general anaesthesia. FVC, FEV1 and PEF decreased by 20% 
in patients receiving TEA, in contrast to 55% in patients after GA on the 
day of operation. 
 
 
 
38 
 
2. Guay Joahne et al, Journal of  Anesth. 2006;20(4):335-40 
   They conducted a meta analysis study regarding the benefits of adding 
epidural analgesia to general anaesthesia in abdominal surgeries.. This 
study included 5402 patients, of which 2660 had had epidural analgesia 
and the remaining general anaesthesia alone.They concluded that epidural 
analgesia  reduces the first 24-h morphine consumption, ( P = 0.003), and 
improves the forced vital capacity (FVC), ( P = 0.001) at 24 h. Also 
reduces the incidence of arrhythmia, ( P = 0.001); ( P = 0.002); intensive 
care unit stay,( P = 0.03); visual analogical pain (VAS) scores at rest, ( P < 
0.00001) and during movement,  ( P < 0.00001 ) 
3. Paul K. Tenenbein et al, Canadian journal of Anaesthesia ;2009, 
volume 55, no:6, 344-350 
They conducted a prospective, randomized, controlled trial in fifty 
patients, undergoing CABG surgery.  Twenty-five patients were enrolled 
in two groups. Patients in the epidural group had significantly less pain on 
the operative day, and for the subsequent two days. Compared to baseline, 
the forced expiratory volume in one second was significantly higher in the 
epidural group, on the first and second postoperative days 
(43.7±12.2%vs 36.4±12.0%,p<0.002, and 43.3±12.5% vs 38.4±11.0%, 
p<0.05). There was significantly more atelectasis in the control group, four 
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hours postoperatively (p<0.04); Hence they concluded that thoracic 
epidural analgesia decreases postoperative pain and atelectasis and 
improves pulmonary function in patients undergoing CABG surgery. 
4. Rigg et al, The Lancet, volume 359, issue 9314, 2002 pg no: 1276 – 82 
A randomized trial was conducted to evaluate epidural anaesthesia and 
analgesia and its outcome in major abdominal surgery. The study included 
915 patients who underwent major abdominal surgeries; they were divided 
in to two groups – one control group (GA only) and the other epidural 
group (GA +epidural). They concluded that improvement in analgesia, 
reduction in respiratory failure, and the low risk of serious adverse 
consequences suggest that many high-risk patients undergoing major 
intraabdominal surgery will receive substantial benefit from combined 
general and epidural anaesthesia intraoperatively with continuing 
postoperative epidural analgesia. 
5. Daniel M Popping et al - Arch Surg. 2008;143(10):990-999;  
A meta analysis study was done evaluating protective effects of epidural 
analgesia on pulmonary complications after abdominal and thoracic 
Surgery. The study was conducted between 1971-2006,in a large number 
of patients and concluded that the incidence of pneumonia with epidural 
analgesia remained about 8% but decreased from 34% to 12% with 
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systemic analgesia (P< .001) ; Also epidural analgesia reduced the need 
for prolonged ventilation or reintubation, improved lung function and 
blood oxygenation. 
6. Ballantyne et al - Anaesthesia and analgesia  March 1998 vol. 86no. 
3 598-612 
   They conducted a  cumulative  meta-analysis  of  randomized,  controlled  
trials on the comparative  effects  of  postoperative  analgesic  therapies  
on  pulmonary  outcome.  
They  assessed  the  effects  of   seven  analgesic  therapies  on  
postoperative  pulmonary  function  after  a  variety  of   procedures:  
epidural  opioid,  epidural  local  anesthetic,  epidural  opioid  with  local  
anesthetic,  thoracic versus lumbar epidural  opioid,  intercostal  nerve  
block,  wound  infiltration  with  local  anesthetic,  and  intrapleural  local  
anesthetic.  Measures  of  forced expiratory  volume  in  1 s (FEV1), forced  
vital  capacity  (FVC),  vital  capacity  (VC),  peak  expiratory  flow  rate  
(PEFR),  Pao2, incidence of atelectasis, pulmonary  infection, and  
pulmonary complications overall were analyzed.  Compared with systemic 
opioids, epidural opioids decreased the incidence of   atelectasis and had a 
weak  tendency  to  reduce  the  incidence of pulmonary infections  and  
pulmonary  complications  overall. Epidural  local  anesthetics  increased 
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pao2 and decreased the  incidence of pulmonary infections  and  pulmonary  
complications  overall  compared  with  systemic  opioids. 
7. Park WY, Thompson JS, Lee KK  ; Ann Surg. 2001 Oct;234(4):560-9; 
569-71. 
They did a randomized, controlled study on effect of epidural anesthesia 
and analgesia on perioperative outcome. 
They studied in 1,021 patients who required anesthesia for one of the 
intraabdominal aortic, gastric, biliary, or colon operations. They were 
assigned randomly to receive either general anesthesia and postoperative 
analgesia with parenteral opioids (group 1) or epidural plus light general 
anesthesia and postoperative epidural morphine (group 2)..  Overall, 
epidural analgesia provides better postoperative pain relief. Epidural 
anesthesia and epidural analgesia improve the overall outcome and 
shorten the  intensive care stay in patients undergoing abdominal aortic 
operations. 
8. THE MASTER TRIAL 
Multicentre Australian study of epidural anaesthesia. 
They investigated the influence of perioperative epidural analgesia on 
postoperative outcome in 888 patients undergoing major abdominal 
surgery in comparison with a control group who received intravenous 
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opioid analgesia. They found decrease in postoperative  respiratory 
failure in the epidural group. Also mean Visual Analogue Score with 
coughing was 30 times less than in control group in first 24 hours.   
9. Miller L, Gertel M.American Journal of Surgery. 1976 Mar;131 (3): 
291-4. 
They compared the effect of narcotic and epidural analgesia on 
postoperative respiratory function.  
A prospective, randomized comparison was made of the value of 
meperidine (intravenous) versus epidural analgesia when used for the 
relief of pain after cholecystectomy in twenty patients without 
cardiopulmonary disease. Respiratory function was assessed the day 
before surgery and at 3 to 4 hours and 24 hours after operation by the 
bedside measurement of expiratory peak flow, vital capacity, and arterial 
blood gases. The two groups of patients were comparable as to age, height, 
weight, smoking habits, preoperative peak flow, vital capacity, and 
duration of operation.  
The arterial oxygen tension and oxygen saturation were significantly 
greater and carbon dioxide tension lower in the epidural analgesia group 
24 hours after operation. At this time peak flow rates and vital capacity 
were not different. However, at 3 to 4 hours postoperatively, vital 
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capacity was significantly greater in the epidural anesthesia group. 
These findings suggest that epidural analgesia is valuable in the early 
postoperative period after upper abdominal surgery 
10.  Gross et al, Anesthesiology Clinical North America. 2000 
Jun;18(2):407-28, They studied on the role of epidural anesthesia and 
analgesia in postoperative outcome. They confirmed the benefits of 
epidural anaesthesia and analgesia in decreasing the incidence of cardiac 
complications in high-risk patients; decreasing incidence of pulmonary 
complications, specifically pneumonia, atelectasis, and hypoxemia in 
patients at risk for pulmonary complications; lower incidence of vascular 
graft occlusion after lower extremity revascularization; lower incidence of 
DVT and pulmonary embolus; suppression of the neuroendocrine stress 
response; and earlier return of gastrointestinal function.  
11. Groeben et al, Journal of Anaesthesia ; Volume 20, Number 
4, 290- 299, 2006 
They concluded in their article -epidural anesthesia and pulmonary 
function as follow: 
  It has been shown that patients who undergo major surgery, such as 
cardiac surgery, under combined anesthesia with epidural anesthesia 
and epidural postoperative analgesia are able to perform VC and 
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FEV1 measurements within 1 hour after extubation, while patients 
without epidural anesthesia and analgesia, and treated with intravenous 
administration of opioids only, were not able to perform pulmonary 
function tests in the first hour. This effect was most likely due to reduced 
vigilance and unsatisfactory pain relief. However, both effects 
significantly compromise lung function and the ability to cough. 
12. Stenseth et al, European Journal of Cardiothoracic 
Surgery. 1996; 10 (10): 859 – 65; They conducted a study evaluating the 
effect of thoracic epidural analgesia on pulmonary function after coronary 
artery bypass surgery. Fifty-four male patients, under 65 years and with an 
ejection fraction of more than 0.5, were randomized into two groups: a 
control group receiving high-dose fentanyl anaesthesia and an epidural 
group receiving low-dose fentanyl anaesthesia + thoracic epidural 
analgesia. They concluded that thoracic epidural analgesia yields a slight, 
but significant, improvement in pulmonary function, most likely due to 
a more profound postoperative analgesia. 
13. H.Kehlet and K.Holte; British Journal of Anaesthesiology 
(2001) 87 (1): 62-72. . Their article reviewed about the effect of 
postoperative analgesia on surgical outcome. 
45 
 
They concuded that the continuous epidural local anaesthetic or local 
anaesthetic–opioid mixtures have only been demonstrated to provide a 
reduction in postoperative pulmonary morbidity in major abdominal 
procedures.  
14. Scott et al,  British. Journal of Anaesthesiology:  (1989) 62 (3) : 
253-257  
They conducted  a randomized, double-blind study in twenty-two patients 
undergoing upper abdominal surgery who received extradural (T7–T8) 
0.5% bupivacaine 9 ml followed by 25 mg h−1 with or without additional 
extradural morphine (bolus 4 mg plus 0.5 mg h−1), for 16 h after 
operation.  There occured total alleviation of pain, and a stable level of 
sensory analgesia and improvement in lung function. 
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MATERIALS AND METHODS 
A prospective randomised double blind study was done to evaluate 
the effect of epidural anaesthesia on pulmonary functions in patients 
undergoing upper abdominal surgery under general anaesthesia. The study 
was carried out in 82 adult patients at Govt Rajaji Hospital, Madurai. 
Patients in the age group of    20 – 60 years with BMI < 28 were selected 
for the study. Study was conducted after getting ethical committee 
approval. 
Patients with chronic obstructive pulmonary disease, smokers, 
expected intraoperative blood loss > 500ml and skeletal deformities were 
excluded from the study. Only patients of ASA I and II physical status 
were chosen to avoid the influence of other medical illness. They were 
divided in to two groups with 42 patients in group GA and 40 patients in 
the other group EGA. For upper abdominal surgeries group GA were 
given general anaesthesia alone and group EGA were given both epidural 
and general anaesthesia. 
PREANAESTHETIC EVALUATION 
1. History 
2. Clinical examination 
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3. Relevant investigations – Hemoglobin,Blood sugar, Renal function tests, 
Electrolytes, ECG, Chest x ray 
4. Informed consent from patients  
METHODS 
All the patients were explained about the pulmonary function testing 
procedure completely and the same was demonstrated to all patients . 
Pulmonary function tests were performed in supine position preoperatively 
and 30 minutes after surgery (postoperatively). After attaching the nasal 
clip and placing the mouthpiece in the mouth with lips completely 
surrounding the mouthpiece, patient was instructed to take deep inspiration 
rapidly and exhale with maximal force without pause to get best results. 
The three parameters of forced indices FEV1, FVC, PEFR were recorded. 
This manouvre was repeated three times and the best of three results was 
chosen.  
EPIDURAL ANAESTHESIA 
Epidural catheter was fixed in group EGA patients before induction. 
Tuohy needle (18 G) was introduced in the epidural space by the loss of 
resistance method at the level of T9 – T10 interspace.  A  catheter (20 G) 
was inserted through the needle and fixed with its tip at T6 – T7 
interspace. Test dose of 3ml of 1.5% lignocaine with epinephrine 15mics 
was given to rule out intrathecal or intravascular spread. Intraoperatively 
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epidural anaesthesia was maintained with 0.25% bupivacaine every 40 
minutes. Epidural analgesia was continued postoperatively for 24 hours 
after surgery with 0.125% bupivacaine. 
GENERAL ANAESTHESIA 
All patients were premedicated with inj. glycopyrrolate 0.2mg im 
and inj midazolam 0.05mg/kg im 45 minutes before surgery after 
performing pulmonary function test. All patients were induced with          
inj propofol 2mg/kg, inj fentanyl 2mics/kg, inj succinylcholine 2mg/kg iv 
and intubated. Inj fentanyl and inj atracurium were used for intraoperative 
maintenance in titrated doses. Patients were reversed with inj neostigmine 
40mics/kg and inj glycopyrrolate 20mics/kg iv and extubated on table. 
 POSTOPERATIVE PERIOD 
Pulmonary function tests were performed in the same manner as did 
in the preoperative period 30 mins after surgery. Three parameters of 
forced indices (FEV1, FVC, PEFR) were recorded again and the best of 
three results were taken and compared. 
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ANALYSIS OF DATA 
The observations were recorded for both the groups as shown in the 
master chart.  
STATISTICAL TOOLS 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2010) 
developed by Centre for Disease Control, Atlanta.  
 Using this software range, frequencies, percentages, means, standard 
deviations, chi square and  'p'  values were calculated. Kruskul Wallis chi-
square test was used to test the significance of difference between 
quantitative variables and Yate’s chi square test for qualitative variables. A 
'p' value less than 0.05 is taken to denote significant relationship. 
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OBSERVATIONS AND RESULTS 
The two groups were comparable in patient characteristics like age, 
sex, weight, and duration of surgery. The diagnosis and the procedure 
done are listed below. 
A : CHARACTERISTICS OF CASES STUDIED :  
TABLE – 1: AGE DISTRIBUTION 
Age group 
G.A. group EGA group 
No % No % 
Upto 20 years 1 2.4 1 2.5 
21- 30 years 2 4.8 5 12.5 
31-40 years 11 26.2 12 30 
41-50 years 24 57.1 17 42.5 
Above 50 years 4 9.5 5 12.5 
Total 42 100 40 100 
Range 20 - 55 years 19 - 55 years 
Mean 43.7 years 41.6 years 
SD 7.8 years 8.7 years 
‘p’ 
0.284 
Not significant 
 
The mean age of the General Anaesthesia Group was 43.7 + 7.8 
years and the Epidural General Anaesthesia Group was 41.6 + 8.7 years. 
There was no statistically significant difference (p = 0.7447). 
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TABLE – 2: SEX DISTRIBUTION 
Sex 
G.A. group EGA group 
No % No % 
Male 24 57.1 20 50 
Female 18 42.9 20 59 
Total 42 100 42 100 
‘p’ 
0.6695 
Not significant 
 
57.1% of the G.A. group and 50% of the E.G.A. group were males. 
There was no significant difference in the sex composition of the two 
groups. (‘p’ > 0.05) 
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TABLE 3: DIAGNOSIS 
Diagnosis 
G.A. group EGA group 
No % No % 
Ca. Stomach 12 28.6 10 25 
Cholelithiasis 10 23.8 13 32.5 
Goo 12 28.6 9 22.5 
Others 
Ca. Easophagus 
CBD stone 
Adhesive obstruction 
Hep. Flex growth 
Ileocecal TB stricture 
Koch abdomen 
Linear abscess 
Splenic flexure growth 
Sigmoid colon growth 
Trans colon growth 
8 
1 
1 
1 
1 
2 
1 
- 
- 
- 
1 
19.0 
2.4 
2.4 
2.4 
2.4 
4.8 
2.4 
- 
- 
- 
2.4 
8 
- 
- 
- 
- 
1 
1 
3 
1 
1 
1 
20 
- 
- 
- 
- 
2.5 
2.5 
7.5 
2.5 
2.5 
2.5 
Total 42 100 40 100 
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TABLE 4 : PROCEDURE 
 
Procedure 
G.A. group EGA group 
No % No % 
Cholecystectomy 11 26.2 13 32.5 
Laparotomy 16 38.1 13 32.5 
TVGJ 12 28.6 9 22.5 
Others 
Adhesiolysis 
Diagnostic laparotomy 
Liver abscess drainage 
Resection and anastomosis 
Trans Hiatal Oesophagectomy 
3 
1 
1 
- 
- 
1 
7.1 
2.4 
2.4 
- 
- 
2.4 
5 
- 
1 
3 
1 
- 
12.5 
- 
2.5 
7.5 
2.5 
- 
Total 42 100 40 100 
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TABLE 5: DURATION OF SURGERY (in Hours) 
Duration in Hours G.A. group EGA group 
Range 2.1 – 3.5 1.9 – 3.2 
Mean 2.49 2.53 
SD 0.27 0.26 
‘p’ 0.5 
Not significant 
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 B: CHANGES IN PRE OPERATIVE AND POST OPERATIVE 
PULMONARY FUNCTION TESTS 
TABLE – 5: CHANGES IN FEV1                                                   
( In percentage of predicted values) 
FEV1 Value 
FEV1 values (in %) 
‘p’ GA group EGA group 
Range Mean SD Range Mean SD
Pre operative 
62 - 
78 
71.0 4.3 60 - 80 69.6 4.8
0.1167 
Not significant
Post 
operative 
17 - 
46 
35.4 6.3 34 - 63 44.8 6.8
0.0001 
Significant 
Difference 
16 - 
48 
35.6 6.6 14 -  32 24.8 4.2
0.0001 
Significant 
 
Percentage of decrease in FEV1 values were 24.8%+4.2% in EGA 
group whereas they were 35.6%+6.6% in the GA group. This is 
statistically significant. (‘P’=0.0001)
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               TABLE – 6: CHANGES IN FVC 
FVC 
FVC values (in %) 
‘p’ GA group EGA group 
Range Mean SD Range Mean SD 
Pre 
operative 
60 - 
79 
70.4 5.7 60 - 80 68.4 5.5 
0.0948 
Not significant 
Post 
operative 
17 - 
47 
34.1 6.1 30 - 56 43.3 6.1 
0.0001 
Significant 
Difference 
26 - 
54 
36.3 5.7 12 - 35 25.1 4.6 
0.0001 
Significant 
 
FVC values decreased by 36.3%+5.7% in the GA group of patients. 
But the decrease was only 25.2%+ 4.6% in the EGA group which was 
statistically significant. 
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TABLE – 7: CHANGES IN PEFR 
PEFR 
PEFR values (in %) 
‘p’ GA group EGA group 
Range Mean SD Range Mean SD 
Pre 
operative 
60 - 80 70.4 6.0 60 - 80 69.0 6.0 
0.2173 
Not significant 
Post 
operative 
11 - 50 36.7 9.0 20 - 57 44.1 8.3 
0.0001 
Significant 
Difference 22 - 49 33.7 6.2 17 - 42 24.9 5.4 
0.0001 
Significant 
 
The decrease in PEFR values in the GA group was 33.7% + 6.2%. 
This is significantly higher than the decrease in the EGA group         
(24.9% +  5.4%) 
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DISCUSSION 
Postoperative  respiratory  dysfunction  is  universally  observed  
after  abdominal  and  thoracic  surgery.  Abnormalities  that  contributes  
to  reduced  lung  volume  and  hypoxaemia  in  postoperative  period  
include  impaired  central  ventilatory  control,  abnormal  pulmonary  
mechanics  due  to  limited  abdominal,  intercostals,  and  diaphragmatic  
muscle  contraction  and  changes  in  pulmonary  circulation  and  gas  
exchange.  These  abnormalities  are  due  not  only  to  sequele  of  
operation  itself,  such  as  tissue  injury  or  pain,  but  also  to  residual  
effects  of  anaesthesia  and  analgesia. 
It is necessary to alleviate pain and improve the respiratory muscle 
tone as early as possible to prevent postoperative pulmonary 
complications and promote early recovery. It is a well known fact that 
epidural technique is simple to perform, safer in skilled hands, and less 
time consuming. By this epidural analgesia, postoperative problems of 
major abdominal surgeries are overcome. 
In this study, forced indices are used to compare the pulmonary 
function tests in postoperative period as they maximally depend on 
respiratory muscular effort and are affected the most in this period. Other 
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pulmonary function test parameters are least affected in the immediate 
postoperative period. 
The two groups were comparable with respect to age, sex, weight 
and duration of surgery. 
Since in the immediate postoperative period it will be cumbersome 
for the patient to do the spirometry test in sitting position with epidural 
anaesthesia, supine position was chosen in this study for both preoperative 
as well as postoperative period. As the procedure was done in supine 
posture, the initial preoperative pulmonary function tests results were 
reduced than the expected 80% of the predicted value. Hence the study 
was standardized in such a way that all patients in the study group 
underwent the pulmonary function tests in supine posture both in 
preoperative and postoperative period.  
FORCED EXPIRATIORY VOLUME IN 1 SECOND: 
The preoperative FEV1 in both groups (GA and EGA) were 
comparable. In the postoperative period, patients in EGA group performed 
the pulmonary function tests well compared with GA group. The reduction 
in postoperative FEV1 from the preoperative value is only 24.8 + 4.2% in 
group EGA compared with group GA where the reduction was 35.6+6.6%  
and which was statistically significant. 
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This outcome is comparable with the study conducted by                
H.Hendolin and his colleagues, which was published in Acta 
Anaesthesiologica Scandinavica which concluded TEA significantly 
prevented the postoperative deterioration of respiratory function as 
compared with general anaesthesia. 
FORCED VITAL CAPACITY 
The preoperative value of FVC both in group GA patients and in 
group EGA patients were comparable. The postoperative value of FVC 
was reduced by 36.3%+5.7%  from the preoperative value in the GA group 
whereas in group EGA the reduction of FVC from the preoperative value 
was only 25.1%+4.6% which again goes by the study conducted by 
H.Hendolin et al and Guay Joahne et al which concluded that TEA 
improves the forced vital capacity (FVC), ( P = 0.001) at 24 h.  
PEAK EXPIRATORY FLOW RATE 
The preoperative values of PEFR were comparable in both GA and 
EGA group patients. There occurred 33.7%+6.2% reduction of PEFR in 
the postoperative period in group GA patients. Whereas only 24.9%+5.4% 
reduction of PEFR occurred in group EGA patients. 
Hence it is clear from the study that overall pulmonary function improve 
even in the immediate postoperative period with epidural anaesthesia 
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compared with general anaesthesia only. This study correlates with the 
study conducted by Scott et al and Daniel M Popping et al which 
concludes the overall improvement in lung function with epidural 
anaesthesia in the postoperative period. 
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SUMMARY 
82 patients of ASA (I &II) undergoing upper abdominal surgeries 
were randomly assigned in two groups, Group GA ( General anaesthesia 
only) and Group EGA (Epidural and General anaesthesia) 
Patients of both the groups were explained and demonstrated about 
the pulmonary function testing procedure. Pulmonary function test was 
done using timed spirogram and the values of forced indices (FEV1,FVC, 
PEFR) were recorded before surgery and 30 minutes after surgery. 
The  observations were: 
1. Reduction of  FEV1 by  29% - 41% in patients of GA group whereas only 
20% - 28% reduction in EGA group. 
2. Reduction of FVC by 31% - 41% in patients of GA group whereas only 
21% - 29% reduction in EGA group. 
3. Patients of GA group showed reduction of PEFR by 28% - 40% whereas 
in EGA group PEFR reduced only by 20% - 30% 
Hence it can be concluded that epidural analgesia reduces the impact 
of general anaesthesia and pain on pulmonary function in the postoperative 
period. 
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CONCLUSION 
 Epidural anaesthesia can be provided safely in appropriate patients 
undergoing major abdominal surgery. It offers a number of proven benefits 
as a result of pain relief, improving the respiratory muscle tone and hence 
pulmonary function. This  study  concluded  that  pulmonary  functions  
are  significantly  improved  by  epidural  anaesthesia,  thus  emphasizing  
epidural  anaesthesia  can  significantly  decrease  pulmonary  morbidity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
BIBLIOGRAPHY 
1. Miller’s text book of anaesthesiology; 7th edition pg no:377 - 383 
2. Nunn’s Text book of Applied Respiratory physiology – 6th edition 
3. Guay Joahne et al,  Journal of  Anesth. 2006;20(4):335-40 The benefits of       
adding epidural analgesia to general anesthesia ; A metaanalysis, 
4. Paul K. Tenenbein et al, Canadian journal of Anaesthesia ; 2009 ,Volume 
55, Number 6, 344-350 ; Thoracic epidural analgesia improves pulmonary 
function in patients undergoing cardiac surgery 
5. H. Hendolin et al, Acta Anaesthesiologica Scandinavica, Volume 31, Issue 
7, pages 645–651, October 1987 ; The effect of thoracic epidural analgesia 
on respiratory function after cholecystectomy 
6. The Lancet, volume 359, issue 9314, 2002 pg no: 1276 – 82 
Epidural anaesthesia and analgesia and outcome of major surgery: a 
randomised trial. Authors :  John RA Rigg DrFANZCA, Konrad Jamrozik 
ProfFAFPHM, Paul S Myles FANZCA, Brendan S Silbert FANZCA, 
Phillip J Peyton FANZCA, Richard W Parsons PhD 
7. Journal of Anaesthesia ; Volume 20, Number 4, 290- 299, 2006 
Epidural anesthesia and pulmonary function - Harald Groeben 
8. Arch Surg. 2008;143(10):990-999;  Protective Effects of Epidural Analgesia 
on Pulmonary Complications After Abdominal and Thoracic Surgery - A 
65 
 
Meta-Analysis , Daniel M. Pöpping, MD ;  Nadia Elia, MD ;  Emmanuel 
Marret, MD  Camille Remy, MD ; Martin R. Tramèr, MD, DPhil  
9. Anaesthesia and analgesia  March 1998 vol. 86no. 3 598-612 
  The  Comparative  Effects  of  Postoperative  Analgesic  Therapies  on  
Pulmonary  Outcome:  Cumulative  Meta-Analyses  of  Randomized,  
Controlled  Trials Jane  C.  Ballantyne,  MB  BS,  FRCA”t,  Daniel  B. Carr,  
MD,  ABPMS,  Sarah  deFerranti,  MD. 
10. Ann Surg. 2001 Oct;234(4):560-9; 569-71. 
Effect of epidural anesthesia and analgesia on perioperative outcome: a 
randomized, controlled Veterans Affairs cooperative study. 
Park WY, Thompson JS, Lee KK 
11. American Journal of Surgery. 1976 Mar;131(3):291-4. 
Comparison of effect of narcotic and epidural analgesia on postoperative 
respiratory function. 
Miller L, Gertel M, Fox GS, MacLean LD. 
12. Anesthesiology. 1993 Apr;78(4):666-76;  22A. 
Postoperative pulmonary complications. Epidural analgesia using 
bupivacaine and opioids versus parenteral opioids. 
Jayr C, Thomas H, Rey A, Farhat F, Lasser P, Bourgain JL 
13. Anesthesiology  Clinical  North America. 2000 Jun;18(2):407-28,  
The role of epidural anesthesia and analgesia in postoperative outcome. 
Grass JA 
66 
 
14. Anaesthesiology 1995 ;June 82(6), 
Epidural anaesthesia and analgesia, their role in postoperative outcome. 
Liu S, Carpenter RL, Neal JM  
15. Ann Surg. 2003 November; 238(5): 663–673.  The Role of Epidural 
Anesthesia and Analgesia in Surgical Practice 
Robert J. Moraca, MD, David G. Sheldon, MD, and Richard C.Thirlby, MD 
16. European Journal of  Cardiothoracic Surgery. 1996;10(10):859-65; . 
Effects of thoracic epidural analgesia on pulmonary function after coronary 
artery bypass surgery. Stenseth R, Bjella L, Berg EM, Christensen 
O, Levang OW, Gisvold SE 
17. British Journal of Anaesthesiology (2001) 87 (1): 62-72 ; H. Kehlet and K. 
Holte. . The effect of postoperative analgesia on surgical outcome. 
18. European society of anaesthesiology , may 2005 
Improving postoperative respiratory outcome 
19. British. Journal of  Anaesthesiology. (1989) 62 (3):253-257  
Continuous thoracic extradural 0.5% bupivacaine with or without morphine; 
Effect on quality of blockade , lung function and the surgical stress 
response. 
20. British Journal of Anaesthesiology, 2003; 91(1) 
New concepts of atelectasis during general anaesthesia. L. Magnusson, 
D.R.Spahn 
 
67 
 
21.     European Journal of Anaesthesiology, Aug 2011; 28(8) 
Physiology of gas exchange during anaesthesia. 
22.  Pansard J-L, Mankikian B, Bertrand M, Kieffer E, Clergue F, Viars P: 
Effects of thoracic extradural block on diaphragmatic electrical activity and 
contractility after upper abdominal surgery. Anaesthesiology 78:63-71, 
1993. 
23. Rosenberg J, Rasmussen V, von Jessen F, Ullstad T, Kehlet H: Late 
postoperative episodic and constant hypoxaemia and associated ECG 
abnormalities. Br J Anaesth 65:684-691, 1990. 
24. Super spiro operating manual – Micro Medical; Aug 2005 
 
 
 
 
                      
 
 
 
 
 
 
 
68 
 
PROFORMA 
EVALUATION OF EFFECT OF EPIDURAL ANAESTHESIA ON 
PULMONARY FUNCTIONS IN PATIENTS UNDERGOING UPPER 
ABDOMINAL SURGERY UNDER  GENERAL ANAESTHESIA 
NAME:                           AGE:                               SEX:                    WEIGHT:              
DIAGNOSIS: 
PROCEDURE: 
DURATION OF SURGERY: 
ANAESTHESIA : GA / EPIDURAL – GA 
PREOPERATIVE PULMONARY FUNCTION TEST 
FORCED INDICES FIRST RECORD SECOND RECORD THIRD RECORD 
FEV1    
FVC    
PEFR    
POSTOPERATIVE PUMONARY FUNCTION TEST 
FORCED INDICES FIRST RECORD SECOND RECORD THIRD RECORD 
FEV1    
FVC    
PEFR    
 
MASTER CHART 
GROUP GA 
S 
NO GROUP NAME AGE SEX
IP 
NO Diagnosis Procedure 
Duration 
(in hrs) 
PRE Operative POST Operative 
FEV1 FVC PEF FEV1 FVC PEF 
1 GA MAHALINGAM  54 M 3752 CA OESOPHAGUS 
TRANS HIATAL 
OESOPHAGECTOMY 3.5 73 64 72 40 32 37 
2 GA PADMAVATHY 45 F 5912 GOO TVGJ 2.3 70 60 63 35 30 34 
3 GA PANDIAMMAL  42 F 5668 GOO TVGJ 2.5 71 79 67 30 25 20 
4 GA SELVAM 38 M 2656 CHOLELITHIASIS CHOLECYSTECTOMY 2.7 70 60 78 36 32 40 
5 GA KARUPPAN 50 M 6430 CA STOMACH LAPARATOMY 2.4 66 64 63 38 35 30 
6 GA SUNDARI 55 F 6811 CA STOMACH LAPARATOMY 2.3 78 72 62 30 28 28 
7 GA SARAVANA KUMAR  32 M 9455 
KOCH 
ABDOMEN 
DIAGNOSTIC 
LAPARATOMY 2.5 76 76 64 31 29 17 
8 GA ANBURAJ 55 M 7513 CA STOMACH LAPARATOMY 2.6 78 70 64 35 29 24 
9 GA DEVRAJ 45 M 6215 GOO TVGJ 2.8 62 61 60 17 17 11 
10 GA VAIRAMANI 46 F 6349 CHOLELITHIASIS CHOLECYSTECTOMY 2.4 76 71 62 46 40 35 
11 GA SUBBAIAH 50 M O380 CA STOMACH LAPARATOMY 2.8 76 72 66 30 34 40 
12 GA MOHAN 48 M 1095 GOO TVGJ 2.1 70 72 78 46 38 50 
13 GA PAPPA 50   F  2981 CA STOMACH LAPARATOMY 2.4 68 72 64 28 34 28 
14 GA SHANMUGAPATHY 45   M   2013 CA STOMACH LAPARATOMY 2.5 76 70 68 40 44 46 
15 GA AYYAKANNU 40   M    4526 GOO TVGJ 2.3 77 78 70 46 36 40 
16 GA RAMAN 40   F 6349 GOO TVGJ 2.2 70 76 79 34 30 46 
17 GA RUKMANI 50     F   5188 CHOLELITHIASIS CHOLECYSTECTOMY 2.9 66 62 70 28 30 28 
18 GA ANBURAJ 45      M  7517 CA STOMACH LAPARATOMY 2.4 72 76 76 40 40 45 
19 GA ACHIMUTHU 38   M 8409 CHOLELITHIASIS CHOLECYSTECTOMY 2.3 70 78 78 46 47 50 
20 GA KAMARAJ 46   M    5108 GOO TVGJ 2.5 78 74 70 36 40 40 
 
 
 
GROUP GA 
SNO GROUP NAME AGE SEX IP NO Diagnosis Procedure 
Duration 
(in hrs) 
PRE Operative POST Operative 
FEV1 FVC PEF FEV1 FVC PEF 
21 GA FATHIMA 40 F 4460 CHOLELITHIASIS CHOLECYSTECTOMY 2.5 70 78 78 35 40 45 
22 GA RAVI 31 M 12993 ILEOCECAL TB- STRICTURE LAPARATOMY 2.4 71 76 78 46 36 40 
23 GA PADMAVATHI 50 F 13180 CHOLELITHIASIS CHOLECYSTECTOMY 2.5 68 66 66 30 28 38 
24 GA VEERALAKSMI 20 F 15107 CHOLELITHIASIS CHOLECYSTECTOMY 2.7 62 78 80 46 47 48 
25 GA MARUDHU 45 M 15009 GOO TVGJ 2.3 66 64 60 24 31 35 
26 GA RAJATHI 48 F 15987 GOO TVGJ 2.3 70 66 68 32 32 36 
27 GA PANDI 38 M 16103 GOO TVGJ 2.5 76 70 76 30 28 34 
28 GA RAAKKU 50 F 17480 CA STOMACH LAPARATOMY 2.2 64 60 66 26 25 30 
29 GA PANDIAMMAL 46 F 17704 CA STOMACH LAPARATOMY 2.8 70 74 68 34 32 35 
30 GA SUNDARAM 40 M 17632 GOO TVGJ 2.4 72 76 77 38 40 44 
31 GA JAYARAM 45 M 36767 CHOLELITHIASIS CHOLECYSTECTOMY 2.6 72 70 78 38 38 40 
32 GA DANABAKIAM 50 F 38843 CBD STONE CHOLECYSTECTOMY 2.1 70 68 72 36 34 30 
33 GA BAGAVATY 26 F 40057 ADHESIVE OBSRUCTION ADHESIOLYSIS 2.4 78 77 78 40 40 45 
34 GA MAGESWARI 30 F 37455 CA STOMACH LAPARATOMY 2.9 68 70 70 34 30 40 
35 GA JEGANADHAN 49 M 35858 CA STOMACH LAPARATOMY 2.3 66 68 70 38 35 30 
36 GA PALANI 55 M 36348 ILEOCECAL TB - STRICTURE LAPARATOMY 2.7 68 66 70 35 32 32 
37 GA KURUVAN 43 M 39945 CHOLELITHIASIS CHOLECYSTECTOMY 2.3 74 76 70 36 36 40 
38 GA CHELLAMAL 45 F 36594 HEP FLEXURE GROWTH LAPARATOMY 2.4 67 70 68 35 36 40 
39 GA SIVALINGAM 37 M 39998 CHOLELITHIASIS CHOLECYSTECTOMY 2.1 74 70 80 36 38 50 
40 GA CHINAPPAN 50 M 41199 GOO TVGJ 3 68 64 65 33 28 30 
41 GA PANDIAMAL 40 F 35903 CA STOMACH LAPARATOMY 2.3 73 75 72 38 40 44 
42 GA RAMASAMY 43 M 37568 TRANS COLON GROWTH LAPAROTOMY 2.6 70 68 73 34 38 45 
 
 
 
 
  
GROUP EGA 
S 
NO GROUP NAME AGE SEX 
IP 
NO Diagnosis Procedure 
Duration 
(in hrs) 
PRE Operative POST Operative 
FEV1 FVC PEF FEV1 FVC PEF 
43 EGA PARAMESWARI 37 F 5649 CHOLELITHIASIS CHOLECYSTECTOMY 2.2 75 77 61 45 42 20 
44 EGA PONNUTHAI 55 F 5723 GOO TVGJ 2.7 72 61 62 43 38 20 
45 EGA RAJESWARI 40 F 54278 CHOLELITHIASIS CHOLECYSTECTOMY 2.5 73 66 63 46 54 33 
46 EGA PRABAKARAN 35 M 92184 LIVER ABSCESS DRAINAGE 2.1 72 61 60 50 42 43 
47 EGA MADHAVI 37 F 5466 CHOLELITHIASIS CHOLECYSTECTOMY 2.6 77 77 62 63 54 41 
48 EGA SUGANTHI 28 F 93039 KOCH ABDOMEN DIAGNOSTIC LAPARATOMY 2.7 67 62 65 42 39 40 
49 EGA MANIMEGALAI 29 F 15818 CHOLELITHIASIS CHOLECYSTECTOMY 2.7 78 76 80 56 50 57 
50 EGA PAPPATHI 38 F 12309 CA STOMACH LAPARATOMY 2.4 76 74 77 48 48 44 
51 EGA KALAIAMMAL 54 F 17304 CA STOMACH LAPARATOMY 2.9 68 66 78 36 40 48 
52 EGA KARUPUDHEVAR 52 M 18690 GOO TVGJ 2.5 64 66 60 40 43 32 
53 EGA JABEELA 45 F 17970 CHOLELITHIASIS CHOLECYSTECTOMY 2.7 66 68 70 48 46 48 
54 EGA MALAICHAMY 40 M 21296 GOO TVGJ 2.7 74 78 77 50 52 50 
55 EGA CHIDAMBARAM 42 M 20276 TRANS COLON GROWTH LAPAROTOMY 3.2 70 64 78 52 36 49 
56 EGA THANGARAJ 51 M 27378 CA STOMACH LAPARATOMY 2.9 66 65 70 34 38 40 
57 EGA SEENIAMMAL 50 F 25051 ILEOCECAL TB - STRICTURE LAPARATOMY 2.4 64 66 66 40 36 38 
58 EGA MANIMALA 28 F 31396 CHOLELITHIASIS CHOLECYSTECTOMY 2.6 78 77 76 52 48 56 
59 EGA MURUGESAN 35 M 31376 GOO TVGJ 2.5 78 74 75 50 50 49 
60 EGA PARGAVI 43 F 31960 GOO TVGJ 2.6 68 66 68 48 38 42 
61 EGA ARULAPPAN 40 M 32006 CHOLELITHIASIS CHOLECYSTECTOMY 2.3 70 74 77 48 50 54 
62 EGA GANESAN 46 M 32405 CA STOMACH LAPARATOMY 2.4 68 66 70 40 40 48 
 
 
 
 
  
GROUP EGA 
S 
NO GROUP NAME AGE SEX 
IP 
NO Diagnosis Procedure 
Duration 
(in hrs) 
PRE Operative POST Operative 
FEV1 FVC PEF FEV1 FVC PEF 
63 EGA SHANTHI 45 F 41545 CHOLELITHIASIS CHOLECYSTECTOMY 2.3 68 70 66 44 50 42 
64 EGA UMASANKARI 32 F 43143 CHOLELITHIASIS CHOLECYSTECTOMY 2.6 73 70 72 50 48 52 
65 EGA TAMIL SELVAM 19 M 42742 CHOLELITHIASIS CHOLECYSTECTOMY 2.5 80 80 78 60 56 56 
66 EGA PERUMAL 37 M 43236 CHOLELITHIASIS CHOLECYSTECTOMY 2.1 68 63 66 36 30 35 
67 EGA MOSES 50 M 43310 CA STOMACH LAPARATOMY 2.9 64 68 64 35 36 43 
68 EGA GUNASEKARAN 50 M 44384 GOO TVGJ 2.8 68 60 67 42 43 42 
69 EGA PERUMAL 50 M 44397 CA STOMACH LAPARATOMY 2.6 65 68 66 40 43 45 
70 EGA VIJAYA 52 F 46587 CHOLELITHIASIS CHOLECYSTECTOMY 2.5 60 61 63 36 34 40 
71 EGA RAMUTHAI 40 F 45761 
SPLENIC 
FLEXURE 
GROWTH 
LAPARATOMY 2.8 
70 68 72 45 42 48 
72 EGA SUSAN 48 M 47684 CA STOMACH LAPARATOMY 2.6 66 65 67 38 40 43 
73 EGA DEEPA 25 F 45740 CHOLELITHIASIS CHOLECYSTECTOMY 2.4 76 74 77 50 46 55 
74 EGA VAIRAMANI 29 M 46757 LIVER ABSCESS DRAINAGE 2.0 70 75 77 50 49 51 
75 EGA BALALAKSMI 47 F 44590 SIGMOID COLON GROWTH 
RESECTION AND 
ANASTAMOSIS 2.7 66 65 62 36 40 39 
76 EGA RAMAKRISHNAN 44 M 36740 GOO TVGJ 2.5 68 65 70 45 42 48 
77 EGA IRULAYEE 45 F 46630 CA STOMACH LAPARATOMY 2.3 67 70 66 38 36 40 
78 EGA MARIMUTHU 48 M 45825 LIVER ABSCESS DRAINAGE 1.9 63 66 69 39 41 45 
79 EGA MUTHAIYA 46 M 50617 GOO TVGJ 2.8 68 65 66 40 41 45 
80 EGA CHINNAPONNU 45 F 50823 CA STOMACH LAPARATOMY 2.6 65 69 67 47 50 50 
81 EGA DURAIPANDI 50 M 48259 GOO TVGJ 2.3 66 60 63 44 40 45 
82 EGA PANDI 36 M 48445 CA STOMACH LAPARATOMY 2.5 70 71 68 46 40 49 
               
 
EVALUATION OF EFFECTS OF EPIDURAL ANAESTHESIA ON       
PULMONARY FUNCTION IN PATIENTS UNDERGOING UPPER 
ABDOMINAL SURGERY UNDER GENERAL ANAESTHESIA. 
 
ABSTRACT 
 
Background 
This is a randomized, prospective study of evaluation of effects of epidural 
anaesthesia on pulmonary function in patients undergoing upper abdominal 
surgery under general anaesthesia. 
Methods  
82 patients of ASA (I &II) undergoing upper abdominal surgeries were randomly 
assigned in two groups, Group GA ( General anaesthesia only/42 patients)  and 
Group EGA (Epidural and General anaesthesia/40 patients). Patients of  both the 
groups were explained and demonstrated about the pulmonary function testing 
procedure. Pulmonary function test was done using timed spirogram and the values 
of forced indices (FEV1, FVC,PEFR) were recorded before surgery and 30 minutes 
after surgery. 
 
 
Observations 
Pulmonary function indices significantly improved in the group EGA after surgery. 
Reduction of  FEV1 by  29% - 41% in patients of GA group whereas only 20% - 
28% reduction in EGA group (p<0.05).  Reduction of FVC by 31% - 41% in 
patients of GA group whereas only 21% - 29% reduction in EGA group (p<0.05). 
Patients of GA group showed reduction of PEFR by 28% - 40% whereas in EGA 
group PEFR reduced only by 20% - 30% (p<0.05). 
Conclusion 
Epidural analgesia significantly reduces the impact of general anaesthesia and pain 
on pulmonary function in the postoperative period. 
Key words 
Pulmonary function test, Epidural analgesia, general anaesthesia, timed spirogram 
 
